Free Alerts   Login
Health Care › Pharmaceutical Preparations

HRTX Stock Price Correlated With Heron Therapeutics Financials

HRTX Stock Price vs. Quarterly
HRTX
Income Statement
Cash Flow
Balance Sheet

HRTX Income Statement

Enable JavaScript and reload
Revenue, Net:
Revenue Per Share:
Cost of Goods & Services Sold:
Gross Profit:
Selling, General & Admin Expense:
Research & Development Expense:
Total Operating Expenses:
Operating Income:
Income Taxes:
Net Income:
Earnings Per Share, Diluted:
Earnings Per Share, Basic:
Shares Outstanding, Basic Avg:
Shares Outstanding, Diluted Avg:
Common Stock Shares Outstanding:

HRTX Cash Flow

Enable JavaScript and reload
Operating Activities Net Income:
Depreciation, Depletion & Amortization:
Change in Accounts Receiveable:
Net Cash from Operations:
Net Cash from Operations Per Share:
Repurchases/Buybacks Common Stock:
Issuance of Long-term Debt:
Cash Dividends Paid:
Net Cash from Financing Activities:
Property, Plant & Equipment Purchases:
Purchases of Businesses, Net of Cash:
Net Cash from Investing Activities:
Net Change in Cash & Equivalents:

HRTX Balance Sheet

Enable JavaScript and reload
Cash and Cash Equivalents:
Short-Term Investments:
Accounts Receivable, Net:
Inventories:
Total Current Assets:
Property, Plant & Equipment, Net:
Total Assets:
Accounts Payable:
Current Portion of Long-Term Debt:
Total Short-Term Liabilities:
Long Term Debt, Non-Current Portion:
Total Long-Term Liabilities:
Total Liabilities:

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Rubric Capital Management Lp
26,713,503 sh
 
$45,413
Vanguard Group
8,338,912 sh
169,632 sh
2%
$14,176
$5,761
Blackrock.
7,162,352 sh
-964,497 sh
-12%
$12,176
$3,805
Velan Capital Investment Management
6,986,744 sh
 
$11,877
Franklin Resources
6,404,795 sh
-553,315 sh
-8%
$10,888
$3,721
Clearline Capital Lp
6,068,554 sh
3,402,570 sh
128%
$10,317
$7,224
Orbimed Advisors
5,928,591 sh
5,125,891 sh
639%
$10,079
$9,252
Tejara Capital
5,275,236 sh
3,165,555 sh
150%
$8,968
$6,795
Palisade Capital Management/Nj
3,646,103 sh
-464,848 sh
-11%
$6,198
$1,964
Adage Capital Partners Gp
2,910,011 sh
910,011 sh
46%
$4,947
$2,887
Geode Capital Management
2,624,674 sh
229,513 sh
10%
$4,463
$1,996
State Street
2,481,845 sh
80,283 sh
3%
$4,219
$1,745
Jw Asset Management
2,292,418 sh
-115,000 sh
-5%
$3,897
$1,417
Orchard Capital Managment
2,243,426 sh
852,346 sh
61%
$3,814
$2,200
Monaco Asset Management Sam
2,226,475 sh
1,529,567 sh
219%
$3,785
$3,067
Renaissance Technologies
1,883,300 sh
1,592,000 sh
547%
$3
Tang Capital Management
1,850,000 sh
 
$3,145
Congress Park Capital
1,798,650 sh
1,209,500 sh
205%
$3,058
$2,451
D. E. Shaw & Co..
1,290,997 sh
1,045,724 sh
426%
$2,195
$1,943
Millennium Management
1,237,157 sh
1,160,465 sh
1513%
$2,103
$2,024

Free historical financial statements for Heron Therapeutics Inc. See how revenue, income, cash flow, and balance sheet financials have changed over 32 quarters since 2016. Compare with HRTX stock chart to see long term trends.

Data imported from Heron Therapeutics Inc SEC filings. Check original filings before making any investment decision.